Robert Avery on Muck Rack

Robert Avery

Verified
As seen in: Chron, MSN, Nature, JAMA (The Journal of the American Medical Association), Stem Cell Reports, Houston Chronicle, Katy Rancher, Kingwood Observer, Pearland Journal, The Bay Area Citizen, The Lancet and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Robert

Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA/LUCERNE

|
By Jennifer Lim, Swiss Visio Montchoisi, Robert Avery 
| ophthalmologyscience.org
Keywords Angiopoietin-2 Faricimab Neovascular age-related macular degeneration Pigment epithelial detachment Retinal pigment epithelium Abbreviations and Acronyms Ang-2 (angiopoietin-2) BCVA (best-corrected visual acuity) CI (confidence interval) CMH (Cochran–Mantel–Haenszel) CNV (choroidal neovascularization) CST (central subfield thickness) IRF (intraretinal fluid) nAMD (neovascular age-related macular degeneration) PED (pigment epithelial detachment) Q4W (every 4 weeks) Q8W (every 8 weeks)...
Open in Who Shared Issue with article?

Gene-Agnostic Gene Therapy Strategies for Inherited Retinal Diseases: Neuroprotection and Immunomodulation Beyond Genetic Correction

|
By S. Patricia Becerra, Robert Maclaren, Robert Avery 
| preprints.org
Submitted: 08 January 2026 You are already at the latest version Background/Objectives: Inherited retinal diseases (IRDs) represent a genetically heterogeneous group of disorders caused by mutations in over 280 genes with more than 3,100 identified variants. While gene-specific replacement therapies have achieved landmark success with voretigene neparvovec (Luxturna) for RPE65-associated retinal dystrophy, developing individual therapies for each genetic subtype remains impractical.
Open in Who Shared Issue with article?

Growing Comfortable with the Suprachoroidal Space

|
By Maria Cruz Berrocal, María H. Berrocal, Robert Avery 
| EyeTube
Growing Comfortable with the Suprachoroidal Space Maria Berrocal, MD, and Robert L. Avery, MD Show Description + Injecting into the suprachoroidal space (SCS) is increasingly popular. What pearls can you learn from Robert L. Avery, MD, who recently published a paper alongside other members of a panel examining best practices for SCS injections? Join him and host Maria Berrocal, MD, as they explore the latest tactics on SCS injection and review keys to success.
Open in Who Shared Issue with article?
See all 3,231 licensed articles (3,923 Total)

Actions

Share this page

Get in touch with Robert

Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified